Guillain-Barré syndrome

Nicholas Shedd¹, Peter Woods^{1

2}, Damon Hoad^{1

2}

Affiliations

¹ Warwick Medical School, University of Warwick, Medical School Building, Coventry, CV4, UK.
² Central England Rehabilitation Unit, Leamington Spa Hospital, Heathcote Lane, Heathcote, Warwick, Warwickshire CV34 6SR, UK.

Case Reports

Nicholas Shedd et al. Evol Med Public Health. 2024.

. 2024 Aug 28;12(1):eoae020.

doi: 10.1093/emph/eoae020. eCollection 2024.

Nicholas Shedd¹, Peter Woods^{1

2}, Damon Hoad^{1

2}

¹ Warwick Medical School, University of Warwick, Medical School Building, Coventry, CV4, UK.
² Central England Rehabilitation Unit, Leamington Spa Hospital, Heathcote Lane, Heathcote, Warwick, Warwickshire CV34 6SR, UK.

No abstract available

Figures

1. Shahrizaila N, Lehmann HC, Kuwabara S.. Guillain-Barré syndrome. Lancet 2021;397:1214–28. - PubMed
1. Laman JD, Huizinga R, Boons G-J. et al.. Guillain-Barré syndrome: expanding the concept of molecular mimicry. Trends Immunol 2022;43:296–308. - PMC - PubMed
1. Christen U. Chapter 4—molecular mimicry. In: Shoenfeld Y, Meroni PL, Gershwin ME (eds.). Autoantibodies (Third Edition). San Diego: Elsevier, 2014, 35–42.
1. Leonhard SE, Bresani-Salvi CC, Lyra Batista JD. et al.. Guillain-Barré syndrome related to zika virus infection: a systematic review and meta-analysis of the clinical and electrophysiological phenotype. PLoS NeglTrop Dis 2020;14:e0008264. - PMC - PubMed
1. Kim J-E, Min YG, Shin J-Y. et al.. Guillain-Barré syndrome and variants following COVID-19 vaccination: report of 13 cases. Front Neurol 2021;12:820723. - PMC - PubMed